APOE and metabolic dysfunction-associated steatohepatitis: In NASH patients, there was an increased prevalence of the APOE e3 allele compared to healthy controls: APOE polymorphism was significantly associated with NASH, particularly the APOE3/3 genotype (Sazci et al., 2008).